Hims & Hers Health (HIMS) Change in Acquisitions & Divestments (2020 - 2026)
Hims & Hers Health (HIMS) reported Change in Acquisitions & Divestments of $93.3 million for Q1 2026, up 197.53% on a YoY basis from $31.3 million in Q1 2025, and down 14.21% sequentially from $108.7 million in Q4 2025.
Hims & Hers Health (HIMS) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $93.3 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 197.53% year-over-year to $93.3 million; the trailing twelve-month figure through Mar 2026 stood at $170.6 million (up 19.66% YoY), and the FY2025 full-year result was $108.7 million, down 47.98% from the prior year.
- Change in Acquisitions & Divestments eased to $93.3 million in Q1 2026, from $108.7 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $208.2 million in Q4 2024 to a low of -$125.4 million in Q3 2024.
- A 5-year average of $40.4 million and a median of $31.3 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments tumbled 14061.02% in 2024 and jumped 197.53% in 2026, its largest moves.
- Tracing HIMS's Change in Acquisitions & Divestments over 5 years: stood at $59.5 million in 2022, then tumbled by 98.49% to $898000.0 in 2023, then jumped by 23086.53% to $208.2 million in 2024, then tumbled by 47.8% to $108.7 million in 2025, then slipped by 14.21% to $93.3 million in 2026.
- Business Quant data shows HIMS's Change in Acquisitions & Divestments at $93.3 million in Q1 2026, $108.7 million in Q4 2025, and -$60.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.25 Mn |
| Mar 31, 2026 | 93.25 Mn |
| Dec 31, 2025 | 108.70 Mn |
| Dec 31, 2025 | 108.70 Mn |
| Sep 30, 2025 | -60.57 Mn |
| Sep 30, 2025 | -60.57 Mn |
| Jun 30, 2025 | 29.23 Mn |
| Jun 30, 2025 | 29.23 Mn |
| Mar 31, 2025 | 31.34 Mn |
| Mar 31, 2025 | 31.34 Mn |
| Dec 31, 2024 | 208.22 Mn |
| Dec 31, 2024 | 208.22 Mn |
| Sep 30, 2024 | -125.37 Mn |
| Sep 30, 2024 | -125.37 Mn |
| Jun 30, 2024 | 28.40 Mn |
| Jun 30, 2024 | 28.40 Mn |
| Mar 31, 2024 | 97.70 Mn |
| Mar 31, 2024 | 97.70 Mn |
| Sep 30, 2023 | 898,000.00 |
| Sep 30, 2023 | 898,000.00 |